Endometrial Carcinoma, Recurrent
1 clinical trials · Condition
◉ Watch Endometrial Carcinoma, Recurrent
| Record | Firm | Date |
|---|---|---|
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer (NCT03015129) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
Track Endometrial Carcinoma, Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.